Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-castrate Prostate Cancer”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT00849121
What this trial is testing

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 17
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04335682
What this trial is testing

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

Who this might be right for
Metastatic Prostate CancerProstate Cancer MetastaticProstate Cancer+3 more
Alliance Foundation Trials, LLC. 111
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Early research (Phase 1)Looking for participantsNCT03460977
What this trial is testing

Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL)
Pfizer 453
Testing effectiveness (Phase 2)Study completedNCT01429064
What this trial is testing

Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 76
Testing effectiveness (Phase 2)Study completedNCT01317641
What this trial is testing

Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 136
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University
Early research (Phase 1)Looking for participantsNCT07090148
What this trial is testing

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Who this might be right for
Prostate Cancer PatientsNon-castrate Prostate CancerRecurrent Prostate Cancer+1 more
University of Wisconsin, Madison 14
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Testing effectiveness (Phase 2)Looking for participantsNCT04969315
What this trial is testing

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

Who this might be right for
Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung Cancer+4 more
Portage Biotech 90
Early research (Phase 1)Study completedNCT01884285
What this trial is testing

AZD8186 First Time In Patient Ascending Dose Study

Who this might be right for
Advanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC
AstraZeneca 147
Not applicableUnknownNCT05612841
What this trial is testing

A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting

Who this might be right for
Prostatic Neoplasm
Centre Hospitalier Universitaire de Besancon 264
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)Study completedNCT00557037
What this trial is testing

A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer

Who this might be right for
Prostate Cancer
MEI Pharma, Inc. 60
Early research (Phase 1)Study completedNCT04768608
What this trial is testing

PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer

Who this might be right for
Castrate-Resistant Prostate Cancer
Zhejiang University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05133440
What this trial is testing

Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06594926
What this trial is testing

Working Out M0 Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Early research (Phase 1)Study completedNCT02740985
What this trial is testing

Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more
AstraZeneca 313
Load More Results